Daewon Pharmaceutical Co. Ltd. (003220) — Long-term Investment Intensity
Daewon Pharmaceutical Co. Ltd. (003220) has a Long-term Investment Intensity of 4.4% as of December 2019. Long-term investments of ₩14.52 Billion represent 4.4% of total assets of ₩327.53 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Daewon Pharmaceutical Co. Ltd. (003220) total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Daewon Pharmaceutical Co. Ltd. Long-term Investment Intensity (2013–2019)
This chart shows how Daewon Pharmaceutical Co. Ltd.'s Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 4.4%, reflecting long-term investments of ₩14.52 Billion against total assets of ₩327.53 Billion KRW. Check 003220 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Long-term Investment Intensity for Daewon Pharmaceutical Co. Ltd. (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Daewon Pharmaceutical Co. Ltd. from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Daewon Pharmaceutical Co. Ltd..
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 4.4% | ₩14.52 Billion | ₩327.53 Billion | ▲ +2.4 pp |
| 2018 | 2.1% | ₩5.69 Billion | ₩275.44 Billion | ▲ +0.8 pp |
| 2017 | 1.3% | ₩2.97 Billion | ₩227.20 Billion | ▲ +0.9 pp |
| 2016 | 0.5% | ₩973.06 Million | ₩214.68 Billion | ▲ +0.2 pp |
| 2015 | 0.2% | ₩462.30 Million | ₩194.75 Billion | ▼ 0.0 pp |
| 2014 | 0.2% | ₩437.85 Million | ₩180.62 Billion | ▼ -0.3 pp |
| 2013 | 0.6% | ₩932.36 Million | ₩160.14 Billion | — |